Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synzi developed and commercialized a virtual care communication platform used by hospitals, health plans, and home health organizations to improve patient engagement, reduce readmissions, and support populations with complex or chronic conditions. The company was acquired by AMN Healthcare in May 2021.
Its technology enables secure video visits, messaging—including translation for limited English proficiency or deaf/hard of hearing patients—and integrates with clients’ existing clinical staff workflows.
No clinical trial results as it does not develop therapeutics.
Customers included AccentCare, Concierge Home Care, Excelin Home Care, Trilogy Home Healthcare.
The company focused on simplicity in its tools to maximize adoption among clinicians.
It was recognized in digital health/telehealth industry collections.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synzi.